Medifast Inc Revenue Growth Rates (MED), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Medifast Inc   (NYSE: MED)
 

MED's Revenue Growth by Quarter and Year

Medifast Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MED Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 76.38
1st Quarter March 75.76
FY 152.14

MEDs Annual Revenue
Medifast Inc 's Revenue in the fiscal year 2025 $ 385.19 millions
Medifast Inc 's Revenue in the fiscal year 2024 $ 601.62 millions
Medifast Inc 's Revenue in the fiscal year 2023 $ 1,071.85 millions
Medifast Inc 's Revenue in the fiscal year 2022 $ 1,598.58 millions
Medifast Inc 's Revenue in the fiscal year 2021 $ 1,526.09 millions




MED Revenue second quarter 2026 Y/Y Growth Comment
Medifast Inc reported fall in Revenue in the second quarter 2026 by -27% to $ 76.38 millions, from the same quarter in 2025.
The drop in the second quarter 2026 Medifast Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 6.66%.

Looking into second quarter 2026 results within Food Processing industry 43 other companies have achieved higher Revenue growth. While Medifast Inc ' s Revenue drop of -27% ranks overall at the positon no. 3608 in the second quarter 2026.


MED Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -36.89 % -37.7 % -43.36 %
3rd Quarter September - -36.16 % -40.66 % -39.71 %
2nd Quarter June -27 % -37.88 % -43.04 % -34.77 %
1st Quarter March -34.26 % -33.87 % -50.06 % -16.43 %
FY   - -36.12 % -43.85 % -

Financial Statements
Medifast Inc 's second quarter 2026 Revenue $ 76.38 millions MED's Income Statement
Medifast Inc 's second quarter 2025 Revenue $ 104.64 millions Quarterly MED's Income Statement


MED Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - -15.77 % -14.8 % -18.85 %
3rd Quarter September - -14.79 % -17.08 % -20.4 %
2nd Quarter June 0.82 % -9.21 % -3.36 % -15.26 %
1st Quarter March 0.88 % -3.15 % -8.75 % 3.48 %
FY (Year on Year)   - -36.12 % -43.85 % -


Back to MED Growth rate Comparisons >> Back to MED Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Food Processing Industry #44
Consumer Non Cyclical Sector #145
Overall #3608

Revenue Y/Y Growth Statistics
High Average Low
90.89 % 6.66 % -50.06 %
(Mar 31 2019)   (Sep 30 2024)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Food Processing Industry #44
Consumer Non Cyclical Sector #145
Overall #3608
Revenue Y/Y Growth Statistics
High Average Low
90.89 % 6.66 % -50.06 %
(Mar 31 2019)   (Sep 30 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Medifast Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
67.19 % -0.7 % -100 %
(Mar 31 2015)  


MED's II. Quarter Q/Q Revenue Comment
Medifast Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 0.82%, to $ 76.38 millions, from $75.76 millions in the first quarter.

Within Food Processing industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Medifast Inc 's Revenue growth quarter on quarter, overall rank is 1653.


Revenue Q/Q Growth Company Ranking
Within: No.
Food Processing Industry #10
Consumer Non Cyclical Sector #56
Overall #1653
Revenue Q/Q Growth Company Ranking
Within: No.
Food Processing Industry #10
Consumer Non Cyclical Sector #56
Overall #1653
Revenue Q/Q Growth Statistics
High Average Low
67.19 % -0.7 % -100 %
(Mar 31 2015)  


MED's II. Quarter Q/Q Revenue Comment
Medifast Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 0.82%, to $ 76.38 millions, from $75.76 millions in the first quarter.

Within Food Processing industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Medifast Inc 's Revenue growth quarter on quarter, overall rank is 1653.


Medifast Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 316.40 $ 344.66 $ 384.14 $ 428.05 $ 478.57
Y / Y Revenue Growth (TTM) -33.89 % -36.45 % -36.13 % -36.44 % -37.78 %
Year on Year Revenue Growth Overall Ranking # 3560 # 2932 # 844 # 1430 # 2839
Seqeuential Revenue Change (TTM) -8.2 % -10.28 % -10.26 % -10.56 % -11.76 %
Seq. Revenue Growth (TTM) Overall Ranking # 3245 # 2847 # 782 # 1314 # 2540


Cumulative Revenue growth Comment
Medifast Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Medifast Inc 's annual Revenue fall would be -33.89% year on year to $316 millions.

In the Consumer Non Cyclical sector 152 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2932 to 3560.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Food Processing Industry # 42
Consumer Non Cyclical Sector # 153
Overall # 3560

Revenue TTM Y/Y Growth Statistics
High Average Low
72.45 %
 5.99 %
-44.68 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 139
S&P 500 # 3245
Cumulative Revenue growth Comment
Medifast Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Medifast Inc 's annual Revenue drop would be -33.89% year on year to $316 millions.

In the Consumer Non Cyclical sector 152 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2932 to 3560.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Food Processing Industry # 42
Consumer Non Cyclical Sector # 153
Overall # 3560

Revenue TTM Y/Y Growth Statistics
High Average Low
72.45 %
5.99 %
-44.68 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 139
S&P 500 # 3245




Other Revenue Growth
Food Processing Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MED's Revenue Growth Ratio versus Food Processing Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2026 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Tyson Foods Inc -0.12%$ -0.115 millions
Tootsie Roll Industries Inc-0.17%$ -0.171 millions
Ascend Wellness Holdings, Inc.-0.93%$ -0.932 millions
Andersons Inc -1.22%$ -1.218 millions
Scotts Miracle gro Co-1.34%$ -1.338 millions
Kraft Heinz Co-1.42%$ -1.417 millions
Willamette Valley Vineyards Inc -1.56%$ -1.564 millions
Post Holdings Inc -1.83%$ -1.829 millions
The Marzetti Company-2.19%$ -2.187 millions
Smithfield Foods Inc -2.30%$ -2.297 millions
Pilgrim s Pride Corporation-2.76%$ -2.755 millions
The Boston Beer Company Inc -3.34%$ -3.335 millions
Niagen Bioscience Inc -4.28%$ -4.281 millions
Mosaic Co-6.04%$ -6.042 millions
J and j Snack Foods Corp -6.19%$ -6.186 millions
Beyond Meat Inc -7.72%$ -7.721 millions
Central Garden and Pet Company-8.09%$ -8.088 millions
Golden Growers Cooperative-8.38%$ -8.378 millions
American Vanguard Corporation-9.17%$ -9.174 millions
Biote Corp -9.48%$ -9.478 millions
Vital Farms Inc -9.66%$ -9.660 millions
Trulieve Cannabis Corp.-10.31%$ -10.306 millions
Reed s Inc -14.98%$ -14.977 millions
Longevity Health Holdings Inc -21.37%$ -21.370 millions
Solesence Inc -22.87%$ -22.866 millions
Upexi Inc -26.57%$ -26.574 millions
Medifast Inc -27.01%$ -27.006 millions
The Hain Celestial Group Inc -27.60%$ -27.599 millions
22nd Century Group inc -29.86%$ -29.855 millions
Hydrofarm Holdings Group Inc -40.17%$ -40.169 millions


About Medifast Inc Revenue Growth Rates (MED), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Medifast Inc (CIK 910329).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-051928
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Medifast Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.